French animal health company VitamFero is looking to secure a licensing deal for its vaccine against bovine neosporosis.
VitamFero eager for second license deal - Animal Pharm
VitamFero : The French biotech with a €1bn pipeline - Animal Pharm
Established in 2005, VitamFero expects its first anti-infective vaccines for food-producing animals to be launched in 2017. The company's debut vaccine – currently under development – will be for ovine toxoplasmosis. The firm hopes to out-license its products to a partner who can take the vaccine through full clinical development.
VitamFero signs up Bioproperties to toxoplasmosis vaccine pact - Animal Pharm
French animal health firm VitamFero has signed an exclusive, worldwide agreement for its animal toxoplasmosis vaccine with Australian company Bioproperties.